Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients

Inclusion Criteria: * Healthy males and females, ≥ 18 years of age at time of informed consent with no upper age limit, seeking treatment for HS scarring in the axillary region. * Subjects must voluntarily sign and date an IRB approved informed consent form. * Subjects with diagnosis of HS (Hidradenitis Suppurativa) scarring recorded over the past 6 months. * Subject has an HS PGA (Hidradenitis Suppurativa Physician's Global Assessment) Scale of 0 or 1 * Able to read, understand and voluntarily provide written informed consent. * Subjects are determined to be healthy, non-smokers. * Subjects able and willing to comply with the treatment protocol and follow-up schedule and requirements. * Understand and accept the obligation not to undergo any other procedures in the areas to be treated through the follow-up period. Exclusion Criteria: * Subject does not have the capacity to consent to the study. * Subject underwent any medical-grade scar treatments (ie, lasers, excision procedures, topical prescriptions for scars) in the past 6 months prior to enrollment in the study. * Any history of keloid scarring. * Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months. * History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy for prior 12 months. * Subject has no health contraindications to receiving local lidocaine and epinephrine injections, i…